Skip to main content

Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.

Publication ,  Journal Article
Grossi, PM; Ochiai, H; Archer, GE; McLendon, RE; Zalutsky, MR; Friedman, AH; Friedman, HS; Bigner, DD; Sampson, JH
Published in: Clin Cancer Res
November 15, 2003

PURPOSE: The monoclonal antibody (MAb) trastuzumab (Herceptin) effectively treats HER2-overexpressing extracerebral breast neoplasms. Delivery of such macromolecule therapeutic agents to intracerebral metastases, however, is limited by the tight junctions characteristic of the cerebral vasculature. Direct intracerebral microinfusion (ICM) is a technique that bypasses this blood-brain barrier and allows for a greater delivery of drugs directly into intracerebral tumors. EXPERIMENTAL DESIGN: A human breast cancer cell line transfected to overexpress HER2, MCF-7/HER2-18, was transplanted into the cerebrum of athymic rats. Saline, trastuzumab, or an isotype-matched control MAb was delivered systemically or by ICM to assess toxicity and efficacy. RESULTS: No clinical or histological toxicity related to trastuzumab was evident under any of the conditions studied. Delivery of trastuzumab (2 mg/kg) i.p. led to a median survival of 26.5 days, whereas treatment with trastuzumab (2 mg/kg) by ICM increased the median survival by 96% to 52 days, with two of nine rats surviving >120 days (P = 0.009). Treatment with an isotype-matched control MAb (16 mg/kg) resulted in a median survival of 21 days, which did not differ significantly from the survival of rats treated by ICM with saline (16 days; P = 0.42). Treatment by ICM with trastuzumab (16 mg/kg) led to a median survival of 45 days, with 2 of 10 rats surviving >120 days. These results represent 181% and 114% increases in median survival over the saline and MAb controls, respectively (P < 0.001). CONCLUSION: ICM of trastuzumab is safe and superior to systemic delivery as therapy for HER2-overexpressing intracerebral neoplasms in an athymic rat model.

Duke Scholars

Published In

Clin Cancer Res

ISSN

1078-0432

Publication Date

November 15, 2003

Volume

9

Issue

15

Start / End Page

5514 / 5520

Location

United States

Related Subject Headings

  • Trastuzumab
  • Survival Analysis
  • Rats, Nude
  • Rats
  • Oncology & Carcinogenesis
  • Neoplasm Metastasis
  • Infusions, Parenteral
  • Female
  • Disease Models, Animal
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grossi, P. M., Ochiai, H., Archer, G. E., McLendon, R. E., Zalutsky, M. R., Friedman, A. H., … Sampson, J. H. (2003). Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin Cancer Res, 9(15), 5514–5520.
Grossi, Peter M., Hidenobu Ochiai, Gary E. Archer, Roger E. McLendon, Michael R. Zalutsky, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, and John H. Sampson. “Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.Clin Cancer Res 9, no. 15 (November 15, 2003): 5514–20.
Grossi PM, Ochiai H, Archer GE, McLendon RE, Zalutsky MR, Friedman AH, et al. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin Cancer Res. 2003 Nov 15;9(15):5514–20.
Grossi, Peter M., et al. “Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.Clin Cancer Res, vol. 9, no. 15, Nov. 2003, pp. 5514–20.
Grossi PM, Ochiai H, Archer GE, McLendon RE, Zalutsky MR, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin Cancer Res. 2003 Nov 15;9(15):5514–5520.

Published In

Clin Cancer Res

ISSN

1078-0432

Publication Date

November 15, 2003

Volume

9

Issue

15

Start / End Page

5514 / 5520

Location

United States

Related Subject Headings

  • Trastuzumab
  • Survival Analysis
  • Rats, Nude
  • Rats
  • Oncology & Carcinogenesis
  • Neoplasm Metastasis
  • Infusions, Parenteral
  • Female
  • Disease Models, Animal
  • Breast Neoplasms